ScholarIQanswers from OpenAlex

Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets

PaperCitations, authors & open-access status

Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets have?

ScholarIQcitation count

Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets has 18 citations in the OpenAlex counts ScholarIQ stores.

When was Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets published?

ScholarIQyear

Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets has 2019 year in the ScholarIQ index.

What is the open-access status of Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets?

ScholarIQoa status

Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets has gold oa status in the ScholarIQ index.

What is the DOI of Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets?

ScholarIQdoi

The DOI for Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets is on the source record.

What is the PMID of Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets?

ScholarIQpmid

The PMID for Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets is on the source record.

What is the OpenAlex record for Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets?

ScholarIQopenalex

The OpenAlex for Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial